First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

NCT01163396 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: 5-fluorouracil/leucovorin

Sponsor

Gruppo Oncologico del Nord-Ovest